HUTCHMED (HCM) News Today GBX 264 -1.00 (-0.38%) (As of 11/15/2024 11:52 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period HUTCHMED (LON:HCM) Share Price Passes Below Two Hundred Day Moving Average - Here's WhyHUTCHMED (LON:HCM) Share Price Passes Below 200 Day Moving Average - What's Next?November 16 at 5:17 AM | marketbeat.comHutchmed to receive $20M milestone payment from Takeda for Fruzaqla salesOctober 31, 2024 | markets.businessinsider.comHUTCHMED (LON:HCM) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?HUTCHMED (LON:HCM) Stock Price Crosses Above Two Hundred Day Moving Average - Here's WhyOctober 26, 2024 | marketbeat.comHUTCHMED (LON:HCM) Shares Pass Above 200-Day Moving Average - Time to Sell?HUTCHMED (LON:HCM) Stock Crosses Above 200 Day Moving Average - What's Next?October 16, 2024 | marketbeat.comHUTCHMED (China) Ltd (HCM) (Q2 2024) Earnings Call Highlights: Strong US Sales Propel Growth ...October 9, 2024 | finance.yahoo.comHUTCHMED (LON:HCM) Share Price Crosses Above 200 Day Moving Average of $284.47HUTCHMED (LON:HCM) Stock Crosses Above Two Hundred Day Moving Average of $284.47September 28, 2024 | marketbeat.comHUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by TakedaSeptember 24, 2024 | markets.businessinsider.comHutchmed Share Chat (HCM)September 20, 2024 | lse.co.ukHUTCHMED (LON:HCM) Stock Crosses Below 200 Day Moving Average of $281.77HUTCHMED (LON:HCM) Shares Pass Below Two Hundred Day Moving Average of $281.77September 4, 2024 | marketbeat.comHUTCHMED (China) Limited: HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in ChinaAugust 31, 2024 | finanznachrichten.deHUTCHMED (LON:HCM) Stock Crosses Below Two Hundred Day Moving Average of $280.85HUTCHMED (LON:HCM) Shares Cross Below 200-Day Moving Average of $280.85August 27, 2024 | marketbeat.comRobust Sales and Expansion Potential Underpin Buy Rating for HUTCHMEDAugust 5, 2024 | markets.businessinsider.com0J7G.IL,0P0001HOP9,145 (0J7G.IL)August 4, 2024 | ca.finance.yahoo.comHCM Aug 2024 25.000 callAugust 4, 2024 | ca.finance.yahoo.comHUTCHMED (China) Limited's (LON:HCM) last week's 6.4% decline must have disappointed private equity firms who have a significant stakeJuly 29, 2024 | finance.yahoo.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM) and PAVmed (PAVM)May 15, 2024 | markets.businessinsider.comHUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board CommitteeMay 8, 2024 | markets.businessinsider.comHUTCHMED (China) (LON:HCM) shareholders are up 8.2% this past week, but still in the red over the last five yearsApril 24, 2024 | finance.yahoo.comHUTCHMED (China) Ltd ADRApril 21, 2024 | morningstar.comLONDON BRIEFING: JD Sports backs outlook; Spirent accepts new offerMarch 28, 2024 | lse.co.ukHCM Mar 2024 30.000 callMarch 15, 2024 | finance.yahoo.comHUTCHMED Hold Rating: Cautious Optimism Amidst Stable Outlook and International Growth PotentialFebruary 28, 2024 | markets.businessinsider.comHUTCHMED (China) Limited: HUTCHMED Reports 2023 Full Year Results and Provides Business UpdatesFebruary 28, 2024 | finanznachrichten.deHutchison China MediTech reports FY resultsFebruary 28, 2024 | msn.comHUTCHMED Reports 2023 Full Year Results and Provides Business UpdatesFebruary 28, 2024 | markets.businessinsider.comHUTCHMED Turns To Profit In FY23, Revenue Surges; Stock Up In Pre-marketFebruary 28, 2024 | markets.businessinsider.comHUTCHMED (China) Ltd (H7T2.BE)February 20, 2024 | au.finance.yahoo.comHUTCHMED (China) Limited's (LON:HCM) biggest owners are private equity firms who got richer after stock soared 4.3% last weekFebruary 20, 2024 | finance.yahoo.comWall Street Analysts See a 75.05% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?February 19, 2024 | msn.comMaintaining Hold on HUTCHMED: Mixed FRUTIGA Results and Fair Valuation Limit UpsideFebruary 7, 2024 | markets.businessinsider.comHUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic PartnershipFebruary 2, 2024 | markets.businessinsider.comHUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic PartnershipFebruary 2, 2024 | finance.yahoo.comHUTCHMED to Announce 2023 Final ResultsFebruary 1, 2024 | finance.yahoo.comHUTCHMED (China) Limited: HUTCHMED Receives ELUNATE (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal CancerJanuary 30, 2024 | finanznachrichten.deHUTCHMED Announces Marketing Approval For ELUNATE By Pharmacy And Poisons Board Of Hong KongJanuary 30, 2024 | markets.businessinsider.comAfter Plunging -10.7% in 4 Weeks, Here's Why the Trend Might Reverse for HUTCHMED (HCM)January 18, 2024 | msn.comHUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology CongressesNovember 30, 2023 | finance.yahoo.comHUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology CongressesNovember 30, 2023 | finance.yahoo.comHUTCHMED (China) Limited - ADR (HCM) Price Target Increased by 5.11% to 26.63November 27, 2023 | msn.comHUTCHMED (China) Stock (NASDAQ:HCM), Analyst Ratings, Price Targets, PredictionsNovember 25, 2023 | benzinga.comHUTCHMED’s Global Expansion and New Product Launches Bolster Buy Rating: An Analysis of Growth Prospects and Market PotentialNovember 24, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: HUTCHMED (HCM), Bayer (OtherBAYRY) and Compass Therapeutics (CMPX)November 10, 2023 | markets.businessinsider.comHUTCHMED (China) Ltd HCMNovember 6, 2023 | morningstar.comHUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2023October 16, 2023 | benzinga.comHUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2023October 16, 2023 | finance.yahoo.comHUTCHMED Announces Submission of New Drug Application for Fruquintinib for Previously Treated Metastatic Colorectal Cancer in JapanSeptember 29, 2023 | stockhouse.comIs HUTCHMED (China) Ltd (HCM) Set to Underperform? Analyzing the Factors Limiting GrowthSeptember 25, 2023 | finance.yahoo.comPrivate equity firms account for 44% of HUTCHMED (China) Limited's (LON:HCM) ownership, while institutions account for 28%September 13, 2023 | finance.yahoo.comHUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in ChinaSeptember 11, 2023 | benzinga.comHUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in ChinaSeptember 11, 2023 | finance.yahoo.com Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Free Cheat Sheet: Build a Dividend Portfolio (Ad)Have you ever wanted to build your own, custom dividend portfolio? A well-rounded portfolio of high quality dividend stocks that produce passive cash flow is one of the best ways to build your nest egg. And, according to one expert, you can do it with a very straightforward process too! These FIVE (FREE) Dividend Investing Cheatsheets Show you How! HCM Media Mentions By Week HCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCM News Sentiment▼1.110.56▲Average Medical News Sentiment HCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCM Articles This Week▼10▲HCM Articles Average Week Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GRI News Today ITH News Today INDV News Today BMY News Today GPH News Today IGC News Today PHAR News Today ARTL News Today KOD News Today AURA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HCM) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
